DGX Quest Diagnostics Inc

Price (delayed)

$150.46

Market cap

$17.14B

P/E Ratio

14.48

Dividend/share

$2.6

EPS

$10.39

Enterprise value

$21.08B

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
The net income has contracted by 43% YoY and by 17% from the previous quarter
DGX's EPS is down by 39% year-on-year and by 16% since the previous quarter

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
113.89M
Market cap
$17.14B
Enterprise value
$21.08B
Valuations
Price to earnings (P/E)
14.48
Price to book (P/B)
2.81
Price to sales (P/S)
1.7
EV/EBIT
11.97
EV/EBITDA
9.64
EV/Sales
2.05
Earnings
Revenue
$10.29B
EBIT
$1.76B
EBITDA
$2.19B
Free cash flow
$1.47B
Per share
EPS
$10.39
Free cash flow per share
$12.65
Book value per share
$53.47
Revenue per share
$88.74
TBVPS
$42.4
Balance sheet
Total assets
$13.22B
Total liabilities
$6.95B
Debt
$4.64B
Equity
$6.24B
Working capital
$732M
Liquidity
Debt to equity
0.74
Current ratio
1.46
Quick ratio
1.24
Net debt/EBITDA
1.8
Margins
EBITDA margin
21.2%
Gross margin
36%
Net margin
12%
Operating margin
17.8%
Efficiency
Return on assets
9.2%
Return on equity
19.4%
Return on invested capital
24.1%
Return on capital employed
15.1%
Return on sales
17.1%
Dividend
Dividend yield
1.73%
DPS
$2.6
Payout ratio
25%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-1.41%
1 week
0.94%
1 month
7.1%
1 year
-2.5%
YTD
-13.03%
QTD
22.63%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$10.29B
Gross profit
$3.7B
Operating income
$1.83B
Net income
$1.24B
Gross margin
36%
Net margin
12%
The net income has contracted by 43% YoY and by 17% from the previous quarter
Quest Diagnostics's net margin has decreased by 39% YoY and by 14% QoQ
DGX's operating income is down by 31% year-on-year and by 12% since the previous quarter
The company's operating margin fell by 26% YoY and by 10% QoQ

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
P/E
14.48
P/B
2.81
P/S
1.7
EV/EBIT
11.97
EV/EBITDA
9.64
EV/Sales
2.05
DGX's EPS is down by 39% year-on-year and by 16% since the previous quarter
DGX's price to earnings (P/E) is 37% higher than its last 4 quarters average of 10.6
The stock's price to book (P/B) is 8% more than its 5-year quarterly average of 2.6 and 8% more than its last 4 quarters average of 2.6
Quest Diagnostics's equity has decreased by 2.7% from the previous quarter and by 2.5% YoY
The revenue has contracted by 7% YoY and by 2.7% from the previous quarter
The stock's price to sales (P/S) is 6% more than its last 4 quarters average of 1.6

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on assets is down by 43% year-on-year and by 16% since the previous quarter
DGX's ROE is down by 43% year-on-year and by 16% since the previous quarter
Quest Diagnostics's return on invested capital has decreased by 40% YoY and by 16% QoQ
DGX's return on sales is down by 37% year-on-year and by 13% since the previous quarter

Dividends

What is DGX's dividend history
DPS
$2.6
Dividend yield
1.73%
Payout ratio
25%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 90% greater than the total liabilities
Quest Diagnostics's quick ratio has decreased by 11% YoY and by 6% QoQ
The current ratio has decreased by 10% YoY and by 5% QoQ
Quest Diagnostics's debt is 26% lower than its equity
The company's debt to equity rose by 2.8% QoQ
Quest Diagnostics's equity has decreased by 2.7% from the previous quarter and by 2.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.